chr19-49930940-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001193646.2(ATF5):c.90C>T(p.Leu30=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0034 in 1,602,986 control chromosomes in the GnomAD database, including 187 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.018 ( 95 hom., cov: 32)
Exomes 𝑓: 0.0019 ( 92 hom. )
Consequence
ATF5
NM_001193646.2 synonymous
NM_001193646.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.93
Genes affected
ATF5 (HGNC:790): (activating transcription factor 5) Enables several functions, including DNA-binding transcription activator activity, RNA polymerase II-specific; RNA polymerase II transcription regulatory region sequence-specific DNA binding activity; and tubulin binding activity. Involved in several processes, including fat cell differentiation; regulation of cell cycle process; and regulation of transcription, DNA-templated. Located in centrosome; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 19-49930940-C-T is Benign according to our data. Variant chr19-49930940-C-T is described in ClinVar as [Benign]. Clinvar id is 782656.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.93 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0616 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ATF5 | NM_001193646.2 | c.90C>T | p.Leu30= | synonymous_variant | 2/3 | ENST00000423777.7 | |
ATF5 | NM_001290746.2 | c.90C>T | p.Leu30= | synonymous_variant | 2/3 | ||
ATF5 | NM_012068.6 | c.90C>T | p.Leu30= | synonymous_variant | 3/4 | ||
ATF5 | XM_011526629.4 | c.90C>T | p.Leu30= | synonymous_variant | 2/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ATF5 | ENST00000423777.7 | c.90C>T | p.Leu30= | synonymous_variant | 2/3 | 1 | NM_001193646.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0180 AC: 2735AN: 152166Hom.: 95 Cov.: 32
GnomAD3 genomes
AF:
AC:
2735
AN:
152166
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00475 AC: 1090AN: 229380Hom.: 33 AF XY: 0.00345 AC XY: 430AN XY: 124590
GnomAD3 exomes
AF:
AC:
1090
AN:
229380
Hom.:
AF XY:
AC XY:
430
AN XY:
124590
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00186 AC: 2695AN: 1450702Hom.: 92 Cov.: 31 AF XY: 0.00158 AC XY: 1140AN XY: 720904
GnomAD4 exome
AF:
AC:
2695
AN:
1450702
Hom.:
Cov.:
31
AF XY:
AC XY:
1140
AN XY:
720904
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0181 AC: 2750AN: 152284Hom.: 95 Cov.: 32 AF XY: 0.0173 AC XY: 1285AN XY: 74462
GnomAD4 genome
AF:
AC:
2750
AN:
152284
Hom.:
Cov.:
32
AF XY:
AC XY:
1285
AN XY:
74462
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 20, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at